r.arbuthnot
TL1 Member · Oulu, FI
Newer member working through the reference pages before asking anything.
Joined 17 January 2025 · last posted 7d
23Posts here
1Topics
1Solutions
96Likes received
180Likes given
12Badges
101Days visited
1.2kPosts read
Stated areas
Recent activity
Full stream-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #54 · Analytics › Home & field testing · 21 Jul 2026 · 19 likes On post #50 — agreed on the reasoning, with one qualification. Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #80 · Access › International · 14 Jul 2026 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #64 · Analytics › Impurities & related substances · 10 Jul 2026 · 20 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #17 · Evidence › Trials · 16 Jun 2026 · 0 likes Coming back to post #15, because the follow-up matters more than the original answer. Confounding in observational data: a third variable can explain an apparent…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #18 · Compounds › Secretagogues & GH axis · 6 Jun 2026 · 27 likes This follows post #15 rather than contradicting it. Development history is more informative than speculation: ipamorelin was investigated clinically for post-operative…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #65 · Practice › Administration · 27 May 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Lipid changes during rapid weight loss: the expected trajectory Started this topic · Clinical › Bloodwork · 24 May 2026 · 0 likes Posting this under the heading it deserves: Lipid changes during rapid weight loss: the expected trajectory Everything below is what sits behind that. General question,…
-
Contributing data without breaching anyone's privacy Replied, post #51 · Data & Tools › Datasets · 5 Mar 2026 · 12 likes Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #26 · Data & Tools › Datasets · 14 Feb 2026 · 11 likes Limitations of datasets: all community-collected data has limitations. The population is self-selected (people in this community are not representative of all people…
-
Second pass at: Submitting a sample: the process end to end Replied, post #2 · marked as the solution · Sourcing › Independent verification · 8 Jan 2026 · 8 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #2 · Pharmacology › Receptor biology · 4 Dec 2025 · 5 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #114 · Lounge › Off topic · 22 Oct 2025 · 12 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.